Navigation Links
Study Links Epilepsy Drug in Pregnancy to Lower IQ
Date:1/23/2013

WEDNESDAY, Jan. 23 (HealthDay News) -- Children of mothers who take the antiepileptic drug valproate during pregnancy have lower IQ scores at age 6, a new study says.

And the higher the dose of valproate during pregnancy, the greater the effect on a child's IQ, according to the report published in the Jan. 22 issue of The Lancet Neurology.

For the study, the researchers looked at 305 pregnant women in the United States and United Kingdom who took a single drug to treat the seizure disorder -- either valproate (Depakote), carbamazepine (Tegretol), lamotrigine (Lamictal) or phenytoin (Dilantin).

At age 6, the IQ of children whose mothers took valproate during pregnancy was seven to 10 points lower than children whose mothers took another antiepileptic drug. Exposure to valproate was also associated with poorer speaking and memory abilities.

"These results build on our earlier work to show that valproate usage during pregnancy has a significant negative effect on children's IQ, which lasts beyond their earliest years," said study leader Kimford Meador, a professor in the neurology department at Emory University in Atlanta.

"IQ at age 6 is strongly predictive of adult IQ and school performance, so our research suggests that valproate use during pregnancy is likely to have long-term negative effects on a child's IQ and other cognitive [mental] abilities," Meador added in a journal news release.

Another expert said the study is practice-changing.

"This important work has changed the way we practice neurology, leading us to conclude that valproate should not be used, if at all possible, in women of child-bearing potential," said Dr. Cynthia Harden, chief of the division of epilepsy and electroencephalography at the Cushing Neuroscience Institute in Manhasset, N.Y.

"The risks of valproate during pregnancy are clearly demonstrated, as the children in this research cohort continue to grow," said Harden.

However, the researchers also found that over time IQ may improve for children exposed to valproate in the womb, and that folic acid supplementation in mothers-to-be may improve children's IQ scores.

Harden called the finding about folic acid's mitigating effect "reassuring and fascinating, since the mechanism of how intrauterine valproate exposure causes cognitive [thinking] and behavioral problems in children is unknown."

For some patients, valproate is the only drug that can control their seizures. This may give particular importance to the findings that higher drug doses have a greater impact on IQ and that folic acid supplementation may have a positive effect on IQ, the researchers said.

Meador said more research in this area is urgently needed, given that many women with epilepsy do not have the option of stopping medication during pregnancy.

After a 2009 study found that taking valproate during pregnancy affected children's IQ at age 3, the U.S. Food and Drug Administration issued a warning that valproate exposure in the womb is associated with impaired mental function in children.

More information

The Epilepsy Foundation has more about pregnancy and epilepsy medications.

-- Robert Preidt

SOURCES: Cynthia Harden, M.D., chief, division of epilepsy and electroencephalography, Cushing Neuroscience Institute, North Shore-LIJ Health System, Manhasset, N.Y.; The Lancet Neurology, news release, Jan. 22, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study: Transparent pricing doesnt curb doctors use of high-cost hospital imaging tests
2. Study shows high blood calcium levels may indicate ovarian cancer
3. New study reveals sex to be pleasurable with or without use of a condom or lubricant
4. Moffitt study shows smoking cessation more successful for cancer patients who quit before surgery
5. Many Suffer Chronic Pain After Breast Cancer Surgery, Study Finds
6. New study examines on/off relationships and sex with an ex among teenagers and young adults
7. Children with egg allergies can safely receive flu vaccine, U-M study says
8. Immune cells engineered in lab to resist HIV infection, Stanford study shows
9. Study explores whether sleeping pills reduce insomniacs suicidal thoughts
10. Study Finds Older Male Scientists Likelier to Commit Research Fraud
11. Study suggests increased diagnosis rate of attention-deficit/hyperactivity disorder at health plan
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Links Epilepsy Drug in Pregnancy to Lower IQ
(Date:3/23/2017)... ... ... feature 150+ Hospital and Health System Executive Speakers including: , , ... of the United States of America: George W. Bush , Boxing Legend, Successful ... Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber McGraw Walsh , ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... help improve all aspects of people’s health and nutrition, announced its product Leyzene ... , Natural Subsistence develops nutritional supplements that help people improve all aspects ...
(Date:3/23/2017)... ... 2017 , ... The American Board of Quality Assurance and Utilization Review Physicians ... to Health Care Quality and Management and Patient Safety. , It is with appreciation ... but also to the Health Care Quality and Patient Safety movements. Diplomates and Members ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... the New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, ... How will the new EU MDR language change the way manufacturers approach ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... “Beyond and ... “Beyond and Back” is the creation of published author Bonetta Rose, a wife, mother ... our lives. , Published by Christian Faith Publishing, Bonetta Rose‘s new book presents actual ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... March 23, 2017  The goal of the ... identify and track prescription drugs as they are distributed ... response to requirements from US FDA to better protect ... dangerous medicines. Blockchain startup Chronicled, which ... chips and blockchain technology and recently raised $6.25M, and ...
(Date:3/23/2017)... Prima BioMed has presented encouraging ... IMP321 in combination with Keytruda, with one of the ... a complete response. Recruitment in the second cohort is ... fully recruited by Q317. Preliminary efficacy data from the ... are expected mid-year (recruitment in the 226-patient Phase IIb ...
(Date:3/23/2017)... , March 23, 2017 ... ended the trading session at 5,821.64, up 0.48%; ... to finish at 20,661.30; and the S&P 500 ... broad based as six out of nine sectors ... has initiated reports coverage on the following Medical ...
Breaking Medicine Technology: